Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Pancreatic Cancer Pathogenesis

  • Vinee Purohit
  • Kamiya Mehla
  • Pankaj K. Singh
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_7188-4



Pancreatic cancer pathogenesis refers to induction and progression of cancer originating from pancreatic cells. Over 95 % of pancreatic tumors are ductal adenocarcinomas. Pancreatic cancer is the fourth leading cause of cancer-associated deaths in the United States (Siegel et al. 2012). The deep-seated anatomical location of pancreas, a lack of clear early symptoms, and high invasiveness of the pancreatic tumor cells cause metastatic spread of the disease even before it is diagnosed. At diagnosis most pancreatic tumors are non-resectable (Hidalgo 2010). Patients undergoing surgical resection face tumor recurrence due to early metastasis. Metastasis often precedes tumor formation, and hence, the genetic alterations in the primary tumors are different from metastases (Rhim et al. 2012). The clinical response to the current therapies is poor, and the 5-year survival rate of the...


Pancreatic Cancer Hepatocyte Growth Factor Pancreatic Cancer Cell Pancreatic Tumor Lynch Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, Idrisoglu S, Nourse C, Nourbakhsh E, Manning S, Wani S, Gongora M, Pajic M, Scarlett CJ, Gill AJ, Pinho AV, Rooman I, Anderson M, Holmes O, Leonard C, Taylor D, Wood S, Xu Q, Nones K, Fink JL, Christ A, Bruxner T, Cloonan N, Kolle G, Newell F, Pinese M, Mead RS, Humphris JL, Kaplan W, Jones MD, Colvin EK, Nagrial AM, Humphrey ES, Chou A, Chin VT, Chantrill LA, Mawson A, Samra JS, Kench JG, Lovell JA, Daly RJ, Merrett ND, Toon C, Epari K, Nguyen NQ, Barbour A, Zeps N, Australian Pancreatic Cancer Genome Initiative, Kakkar N, Zhao F, Wu YQ, Wang M, Muzny DM, Fisher WE, Brunicardi FC, Hodges SE, Reid JG, Drummond J, Chang K, Han Y, Lewis LR, Dinh H, Buhay CJ, Beck T, Timms L, Sam M, Begley K, Brown A, Pai D, Panchal A, Buchner N, De Borja R, Denroche RE, Yung CK, Serra S, Onetto N, Mukhopadhyay D, Tsao MS, Shaw PA, Petersen GM, Gallinger S, Hruban RH, Maitra A, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL, Morgan RA, Lawlor RT, Capelli P, Corbo V, Scardoni M, Tortora G, Tempero MA, Mann KM, Jenkins NA, Perez-Mancera PA, Adams DJ, Largaespada DA, Wessels LF, Rust AG, Stein LD, Tuveson DA, Copeland NG, Musgrove EA, Scarpa A, Eshleman JR, Hudson TJ, Sutherland RL, Wheeler DA, Pearson JV, McPherson JD, Gibbs RA, Grimmond SM (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491(7424):399–405PubMedCentralCrossRefPubMedGoogle Scholar
  2. Dugan MC, Dergham ST, Kucway R, Singh K, Biernat L, Du W, Vaitkevicius VK, Crissman JD, Sarkar FH (1997) HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival. Pancreas 14(3):229–236CrossRefPubMedGoogle Scholar
  3. Friess H, Berberat P, Schilling M, Kunz J, Korc M, Büchler MW (1996) Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J Mol Med (Berl) 74(1):35–42CrossRefGoogle Scholar
  4. Hidalgo M (2010) Pancreatic cancer. N Engl J Med 362(17):1605–1617CrossRefPubMedGoogle Scholar
  5. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, Jacobetz MA, Ross S, Conrads TP, Veenstra TD, Hitt BA, Kawaguchi Y, Johann D, Liotta LA, Crawford HC, Putt ME, Jacks T, Wright CV, Hruban RH, Lowy AM, Tuveson DA (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4(6):437–450CrossRefPubMedGoogle Scholar
  6. Hruban RH, Goggins M, Parsons J, Kern SE (2000) Progression model for pancreatic cancer. Clin Cancer Res 6(8):2969–2972PubMedGoogle Scholar
  7. Hruban RH, Maitra A, Kern SE, Goggins M (2007) Precursors to pancreatic cancer. Gastroenterol Clin North Am 36(4):831–849, viPubMedCentralCrossRefPubMedGoogle Scholar
  8. Jean ME, Lowy AM, Chiao PJ, Evans DB (2002) The molecular biology of pancreatic cancer. Pancreatic cancer: M. D. Anderson solid tumor oncology series. Springer, New York, pp 15–28Google Scholar
  9. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Kamiyama H, Jimeno A, Hong SM, Fu B, Lin MT, Calhoun ES, Kamiyama M, Walter K, Nikolskaya T, Nikolsky Y, Hartigan J, Smith DR, Hidalgo M, Leach SD, Klein AP, Jaffee EM, Goggins M, Maitra A, Iacobuzio-Donahue C, Eshleman JR, Kern SE, Hruban RH, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321(5897):1801–1806PubMedCentralCrossRefPubMedGoogle Scholar
  10. Kern SE, Shi C, Hruban RH (2011) The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting. J Pathol 223(2):295–306PubMedCentralCrossRefPubMedGoogle Scholar
  11. Kopp JL, von Figura G, Mayes E, Liu FF, Dubois CL, Morris JP 4th, Pan FC, Akiyama H, Wright CV, Jensen K, Hebrok M, Sander M (2012) Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22(6):737–750PubMedCentralCrossRefPubMedGoogle Scholar
  12. Lowy DR, Willumsen BM (1993) Function and regulation of ras. Annu Rev Biochem 62:851–891CrossRefPubMedGoogle Scholar
  13. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, McAllister F, Reichert M, Beatty GL, Rustgi AK, Vonderheide RH, Leach SD, Stanger BZ (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148(1-2):349–361PubMedCentralCrossRefPubMedGoogle Scholar
  14. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1):10–29CrossRefPubMedGoogle Scholar
  15. Quan M, Wang P, Cui J, Gao Y, Xie K (2013) The roles of FOXM1 in pancreatic stem cells and carcinogenesis. Molecular Cancer 12:159PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.The Eppley Institute for Research in Cancer and Allied Diseases, and Department of Pathology and MicrobiologyUniversity of Nebraska Medical CenterOmahaUSA
  2. 2.The Eppley Institute for Research in Cancer and Allied DiseasesUniversity of Nebraska Medical CenterOmahaUSA
  3. 3.The Eppley Institute for Research in Cancer and Allied Diseases, and Department of Pathology and Microbiology, and Department of Biochemistry and Molecular Biology, and Department of Genetic Cell Biology and AnatomyUniversity of Nebraska Medical CenterOmahaUSA